Given the prominent effects of angiotensin II on vascular growth, we quantified tumor expression of VEGFA by ELISA, and found VEGFA levels were significantly decreased in tumors of Losartan-treated animals (Figure 3c, P < 0.05) and a possible downstream effect of reduced IL-6 levels in response to AT1R inhibition [31]. This evidence concerns the gene VEGFA and neoplasm.